Legal & General Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-86,669
| Closed | -$815K | – | 3511 |
|
|
2020
Q3 | $815K | Sell |
86,669
-8,678
| -9% | -$82.5K | ﹤0.01% | 2086 |
|
|
2020
Q2 | $729K | Buy |
95,347
+7,775
| +9% | +$59.5K | ﹤0.01% | 2075 |
|
|
2020
Q1 | $541K | Buy |
87,572
+1,319
| +2% | +$11.6K | ﹤0.01% | 2045 |
|
|
2019
Q4 | $1.05M | Buy |
86,253
+3,275
| +4% | +$35.8K | ﹤0.01% | 2056 |
|
|
2019
Q3 | $958K | Buy |
82,978
+3,091
| +4% | +$32.5K | ﹤0.01% | 2000 |
|
|
2019
Q2 | $798K | Sell |
79,887
-1,971
| -2% | -$21.3K | ﹤0.01% | 2023 |
|
|
2019
Q1 | $1.05M | Sell |
81,858
-2,581
| -3% | -$38.4K | ﹤0.01% | 1953 |
|
|
2018
Q4 | $1.29M | Buy |
84,439
+1,980
| +2% | +$37.7K | ﹤0.01% | 1811 |
|
|
2018
Q3 | $1.65M | Buy |
82,459
+14,664
| +22% | +$334K | ﹤0.01% | 1776 |
|
|
2018
Q2 | $1.34M | Buy |
67,795
+3,827
| +6% | +$84.7K | ﹤0.01% | 1826 |
|
|
2018
Q1 | $1.25M | Sell |
63,968
-4,593
| -7% | -$77.7K | ﹤0.01% | 1815 |
|
|
2017
Q4 | $909K | Hold |
68,561
| – | – | ﹤0.01% | 1912 |
|
|
2017
Q3 | $1.26M | Buy |
68,561
+749
| +1% | +$14K | ﹤0.01% | 1771 |
|
|
2017
Q2 | $1.25M | Buy |
67,812
+6,441
| +10% | +$128K | ﹤0.01% | 1755 |
|
|
2017
Q1 | $1.38M | Buy |
61,371
+770
| +1% | +$18.4K | ﹤0.01% | 1668 |
|
|
2016
Q4 | $2.11M | Buy |
60,601
+28,705
| +90% | +$858K | ﹤0.01% | 1358 |
|
|
2016
Q3 | $779K | Buy |
31,896
+22,404
| +236% | +$560K | ﹤0.01% | 1500 |
|
|
2016
Q2 | $226K | Hold |
9,492
| – | – | ﹤0.01% | 1731 |
|
|
2016
Q1 | $221K | Buy |
9,492
+2,870
| +43% | +$68.1K | ﹤0.01% | 1705 |
|
|
2015
Q4 | $198K | Buy |
6,622
+666
| +11% | +$21.5K | ﹤0.01% | 1749 |
|
|
2015
Q3 | $233K | Buy |
5,956
+302
| +5% | +$18.7K | ﹤0.01% | 1632 |
|
|
2015
Q2 | $382K | Buy |
5,654
+655
| +13% | +$41.2K | ﹤0.01% | 1413 |
|
|
2015
Q1 | $277K | Buy |
4,999
+1,008
| +25% | +$48K | ﹤0.01% | 1537 |
|
|
2014
Q4 | $175K | Sell |
3,991
-332
| -8% | -$12K | ﹤0.01% | 1641 |
|
|
2014
Q3 | $138K | Buy |
+4,323
| New | +$92.2K | ﹤0.01% | 1701 |
|
Legal & General Group's AMAG Position: Q4 2020 in Review
Legal & General Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 86,669 shares — an estimated $815K sold.
Legal & General Group first reported a position in AMAG in Q3 2014 and held it in 25 quarters. The position peaked at $2.11M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Legal & General Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Legal & General Group sold 86,669 AMAG Pharmaceuticals shares in Q4 2020, an estimated $815K.
- Legal & General Group first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 25 quarters.
- Legal & General Group's AMAG Pharmaceuticals position peaked at $2.11M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Legal & General Group's 13F filing for Q4 2020, filed 12 Feb 2021.